Clinical trial
Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by…
NCT00459979 · Case Comprehensive Cancer Center, Other · Completed
Key facts
| NCT number | NCT00459979 |
|---|---|
| Title | Sunitinib in Treating Patients With Kidney Cancer That Cannot Be Removed by Surgery |
| Official title | A Phase II Study of Sunitinib Malate in Patients With Renal Cell Carcinoma and Unresectable Primary Tumors |
| Lead sponsor | Case Comprehensive Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Kidney Cancer |
| Intervention type | Drug, Procedure |
| Interventions | sunitinib malate, conventional surgery |
| Enrollment | 30 |
| Start date | Mar 1, 2007 |
| Primary completion | Mar 1, 2011 |
| Completion | Sep 1, 2013 |
| First posted | Apr 13, 2007 |
| Last update posted | Mar 7, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: